Research into hematological cancers

With the aim of advancing treatments for hematological cancers, patients treated at Institut Curie can participate in therapeutic trials, with their authorization.
Institut Curie is deeply involved in clinical research networks for myeloma and lymphoma; translational research for lymphoma; and basic research for acute myeloid leukemia and myelodysplasia.